Subscribe

NexgenRx Inc. (NEGXF)

USD0.33 +0.00 (+0.00%)
CA OTC Healthcare Medical - Healthcare Plans
Address 185 The West Mall M9C 5L5
Toronto, ON, CA
CEO Ronald C. Loucks
IPO 2017-12-18
ISIN CA65337X1042

Explore sections of this company profile

Description

NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disbursement of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.33 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
774
Beta
0.53
Float Shares
44.82M
Free Float %
63.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% -3.57% +35.00% -3.57% +35.00% +10.79% -27.24% +40.99% +40.99%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.33
DCF (Unlevered) 0.85 +161.8%
DCF (Levered) 0.79 +141.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
1.28
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Healthcare Plans: +11.8%
    +6.0% Q1'26: +7.7% (vs Q1'25)
  • EPS growth Medical - Healthcare Plans: -1.4%
    +174.0% Q1'26: +158.3% (vs Q1'25)
  • FCF margin FCF growth · Medical - Healthcare Plans: +15.1%
    -7.3% Q1'26: -81.9% (vs Q1'25)
  • EBIT margin Medical - Healthcare Plans: +3.3%
    +10.2% Q1'26: +23.3% (vs Q1'25)
  • ROIC Medical - Healthcare Plans: +6.7%
    Q1'26: -17.4% (vs Q1'25)
  • Share dilution Medical - Healthcare Plans: +2.1%
    +0.7% Q1'26: +0.4% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Plans: 0.93×
    0.12× Q1'26: 0.06× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.45) × ERP
WACC = 99% × Ke + 1% × Kd (47.4%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 0.85 Current price: 0.33
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
7.94M
OE per share TTM
0.11
Owner's Yield
41.37%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
5.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
88.8K
Shares Outstanding
71.12M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Ronald C. Loucks Founder, Chief Executive Officer, President & Director 339.9K male
Andrew Munroe Vice President of Operations 150.9K male
J. Padda Director of Implementation 147.2K male
Kelly Ehler Chief Financial Officer 43.9K male
Doreen Harvey Lead Human Resources female
Paul Anthony Bolger Company Secretary male
Richard Stevens Vice President of Administration male
Avik Debroy Financial Controller male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits